Cline Christopher R. - Insider Non-Derivative Transactions at Travere Therapeutics, Inc. (TVTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 9, 2024, Cline Christopher R.'s relationship to Travere Therapeutics, Inc. (TVTX) is Officer (CHIEF FINANCIAL OFFICER), and currently has 74,595 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TVTX insiders.
Data Source: SEC.
Cline Christopher R. - Insider Non-Derivative Transactions of TVTX Common Stock
Cline Christopher R. - Insider Non-Derivative Transactions at TVTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 10, 2024 | Sell -- (Common Stock) | 2490 | 11.52 | 74595 |
| Sep 6, 2024 | Acquisition -- (Common Stock) | 6750 | 0 | 77085 |
| Sep 5, 2024 | Sell -- (Common Stock) | 514 | 9.51 | 70335 |
| Apr 12, 2024 | Sell -- (Common Stock) | 54 | 6.74 | 70849 |
| Feb 2, 2024 | Sell -- (Common Stock) | 3818 | 8.53 | 70903 |
| Feb 1, 2024 | Acquisition -- (Common Stock) | 25000 | 0 | 74721 |
| Jan 24, 2024 | Sell -- (Common Stock) | 853 | 9.07 | 49721 |
| Sep 6, 2023 | Sell -- (Common Stock) | 457 | 14.71 | 50574 |
| May 11, 2023 | Sell -- (Common Stock) | 455 | 16.59 | 51031 |
| Apr 12, 2023 | Sell -- (Common Stock) | 47 | 21.49 | 51486 |
| Feb 2, 2023 | Sell -- (Common Stock) | 1588 | 21.75 | 51533 |
| Feb 1, 2023 | Acquisition -- (Common Stock) | 20250 | 0 | 53121 |
| Jan 25, 2023 | Sell -- (Common Stock) | 852 | 21.9 | 32871 |